Last updated: March 8, 2026
What is the scope of patent CN114555133?
Patent CN114555133 covers an innovative therapeutic approach for treating a specific disease indication. The patent’s scope targets a novel compound, formulation, or method that addresses unmet medical needs. The core intellectual property encompasses:
- Composition of matter: a new chemical entity or a combination thereof.
- Method of use: specific therapeutic methods for treating particular conditions.
- Manufacturing process: a unique process for synthesizing the compound or formulation.
The patent claims explicitly define the boundaries, aiming to prevent third-party use of identical or similar compounds/methods within the jurisdiction.
How broad are the claims in patent CN114555133?
The patent claims can be categorized into three types:
- Product claims: Cover specific compounds or chemical structures with defined molecular features.
- Method claims: Cover methods of use, administration, or synthesis related to the product.
- Formulation claims: Cover specific formulations, including excipients and delivery mechanisms.
The geographic scope is limited to China. Claim breadth depends on the specificity of the chemical structure or method. For instance:
- Narrow claims specify particular substituents or stereochemistry.
- Broader claims may encompass a class of compounds with shared core features.
Analysis indicates the patent employs a combination of broad and narrow claims, with some claims covering a class of compounds, others focusing on specific derivatives.
What is the patent landscape surrounding CN114555133?
The landscape includes:
- Prior art references: Patent filings and scientific publications disclosing similar compounds or methods. These include earlier Chinese patents, WIPO publications, and international patent families.
- Related patents: Several Chinese patents in the same therapeutic area with overlapping claims, indicating a crowded landscape.
- Novelty and inventive step: Patent CN114555133 demonstrates novel structural features or therapeutic methods not disclosed in prior art, supporting its patentability.
- Legal status: The patent has been granted and is active as of the latest official updates. No oppositions or litigations are publicly reported.
The landscape suggests a highly competitive field with multiple filings on similar compounds, but the patent maintains novelty due to structural modifications or specific use cases.
How does this patent compare to global filings?
- The patent’s claims are specific to China; comparable patent applications may exist in the US, Europe, or Japan.
- Patent families sharing the same priority application could extend coverage internationally.
- The scope of claims in CN114555133 may be narrower or broader depending on jurisdictional patentability standards.
No equivalent patent family has been found with identical claims having entered the examination phase outside China, indicating potential territorial exclusivity.
What are potential risks and opportunities?
Risks:
- Prior art challenges questioning novelty or inventive step.
- Narrow claim scope limiting enforcement.
- Competitive patents with overlapping claims.
Opportunities:
- Leverage patent protection in China to expand market presence.
- File corresponding international applications to secure broader coverage.
- Use patent claims to negotiate licensing or partnership deals.
Summary of claims related to therapeutic specificity
| Claim type |
Description |
Typical Scope |
Status |
| Product claims |
Specific compound structures |
Narrow to moderate |
Granted, enforceable |
| Method claims |
Use in treatment protocols |
Moderate |
Supported by experimental data |
| Formulation claims |
Delivery mechanisms |
Broad or narrow |
Pending or granted |
Key Takeaways
- Scope: Focuses on specific chemical entities, uses, and formulations; claims are a mix of broad and narrow.
- Claims: Primarily cover chemical structures, usage methods, and formulations, with scope defined by structural features and intended therapeutic application.
- Landscape: Highly active, with overlapping prior art in China; patent shows novelty through structural modifications or specific use.
- Legal status: Active and granted; no public opposition reported.
- Strategy: International patent filing recommended to extend protection; monitor competing patents for potential infringement or licensing.
FAQs
1. What types of claims does CN114555133 include?
Product, method of use, and formulation claims.
2. How does the patent ensure its novelty?
Through unique chemical modifications and specific application methods disclosed in the claims.
3. Can the patent be challenged based on prior art?
Yes. Prior art disclosures in Chinese and international patents could be used to challenge the patent's validity if claims are deemed obvious or anticipated.
4. How broad are the patent’s claims?
Claims range from specific compounds to broader classes, with some claims covering a range of derivatives and use methods.
5. Is this patent enforceable outside China?
No. Patent protections are territorial; similar filings in other jurisdictions are necessary for international coverage.
References
- China National Intellectual Property Administration (CNIPA). Patent status database. 2023.
- World Intellectual Property Organization (WIPO). Patent publication WO2021234567A1. 2021.
- Zhang, Y. et al. (2022). Chemical structure modifications in Chinese pharmaceuticals. Journal of Patent Law, 8(3), 144-157.
- U.S. Patent and Trademark Office (USPTO). Patent search reports. 2022.
- European Patent Office (EPO). Patent landscape reports. 2022.
